000 01718 a2200505 4500
005 20250517074443.0
264 0 _c20171019
008 201710s 0 0 eng d
022 _a1436-3771
024 7 _a10.1007/s00784-015-1706-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZafar, S
245 0 0 _aEffects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.
_h[electronic resource]
260 _bClinical oral investigations
_cNov 2016
300 _a2023-2035 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAlveolar Process
_xcytology
650 0 4 _aApoptosis
650 0 4 _aBiomarkers
_xanalysis
650 0 4 _aBone Density Conservation Agents
_xpharmacology
650 0 4 _aCell Movement
_xdrug effects
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aDiphosphonates
_xpharmacology
650 0 4 _aDiterpenes
_xpharmacology
650 0 4 _aFemale
650 0 4 _aGene Expression
650 0 4 _aHumans
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aMicroscopy, Electron, Transmission
650 0 4 _aMiddle Aged
650 0 4 _aOsteoblasts
_xdrug effects
650 0 4 _aReal-Time Polymerase Chain Reaction
650 0 4 _aZoledronic Acid
700 1 _aCoates, D E
700 1 _aCullinan, M P
700 1 _aDrummond, B K
700 1 _aMilne, T
700 1 _aSeymour, G J
773 0 _tClinical oral investigations
_gvol. 20
_gno. 8
_gp. 2023-2035
856 4 0 _uhttps://doi.org/10.1007/s00784-015-1706-y
_zAvailable from publisher's website
999 _c25656089
_d25656089